| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Referees
|
|
|
|
49 |
6 |
p. 657-659
|
artikel
|
| 2 |
Assessment of Abuse Liability and Nicotine Pharmacokinetics of glo Heated Tobacco Products in a Randomized, Crossover Study
|
Kanobe, Milly N.
|
|
|
49 |
6 |
p. 733-750
|
artikel
|
| 3 |
Comparison of Vancomycin AUC24 Calculation Methods for Neonates and Infants
|
Laitila, Tuomas
|
|
|
49 |
6 |
p. 773-779
|
artikel
|
| 4 |
Does Age Influence Immunosuppressant Drug Pharmacokinetics in Kidney Transplant Recipients?
|
Cossart, Amelia R.
|
|
|
49 |
6 |
p. 751-761
|
artikel
|
| 5 |
Novel Fimasartan Fluidized Solid Dispersion and Its Tablet: Preparation, Crystallinity, Solubility, Dissolution, and Pharmacokinetics in Beagle Dogs
|
Shin, Dong Chul
|
|
|
49 |
6 |
p. 723-732
|
artikel
|
| 6 |
Personalized Medicine Approach to Proteomics and Metabolomics of Cytochrome P450 Enzymes: A Narrative Review
|
Fetse, John
|
|
|
49 |
6 |
p. 661-676
|
artikel
|
| 7 |
Pharmacokinetic and Pharmacodynamic Interaction of Finerenone with Diltiazem, Fluconazole, and Ritonavir in Rats
|
Bui, Tham Thi
|
|
|
49 |
6 |
p. 701-714
|
artikel
|
| 8 |
Pharmacokinetic Model of Drug Interaction of Tacrolimus with Combined Administration of CYP3A4 Inhibitors Voriconazole and Clarithromycin After Bone Marrow Transplantation
|
Hirai, Toshinori
|
|
|
49 |
6 |
p. 763-771
|
artikel
|
| 9 |
Prediction of First-in-Human Dose of Chimeric Antigen Receptor-T (CAR-T) Cells from Mice
|
Mahmood, Iftekhar
|
|
|
49 |
6 |
p. 715-722
|
artikel
|
| 10 |
Vancomycin in Pediatric Patients with Cystic Fibrosis: Dose Optimization Using Population Pharmacokinetic Approach
|
Yaliniz, Aysenur
|
|
|
49 |
6 |
p. 677-687
|
artikel
|
| 11 |
Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug–Drug Interaction Between Voriconazole and Flucloxacillin
|
Abdullah-Koolmees, Heshu
|
|
|
49 |
6 |
p. 689-699
|
artikel
|
Tijdschrift beschrijving